We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+24.45%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$416M
AUM Growth
+$86.4M
Cap. Flow
+$12M
Cap. Flow %
2.89%
Top 10 Hldgs %
20.32%
Holding
270
New
32
Increased
111
Reduced
38
Closed
36

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$5.82M
2
HUM icon
Humana
HUM
+$5.53M
3
DXCM icon
DexCom
DXCM
+$5.36M
4
LDOS icon
Leidos
LDOS
+$5.21M
5
CIEN icon
Ciena
CIEN
+$5.2M

Top Sells

Rank Stock Value
1
DOV icon
Dover
DOV
+$4.31M
2
RTN
Raytheon Company
RTN
+$3.93M
3
XYL icon
Xylem
XYL
+$3.92M
4
NVR icon
NVR
NVR
+$3.84M
5
NSC icon
Norfolk Southern
NSC
+$3.82M

Sector Composition

Rank Sector Weight
1 Technology 30.93%
2 Healthcare 18.12%
3 Industrials 9.94%
4 Financials 7.57%
5 Communication Services 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
26
Edwards Lifesciences
EW
$49.4B
$4.9M 1.18%
70,907
+728
+1% +$51.7K
VRSN icon
27
VeriSign
VRSN
$25.3B
$4.9M 1.18%
+23,676
New +$4.91M
BWXT icon
28
BWX Technologies
BWXT
$15.7B
$4.87M 1.17%
85,943
+639
+0.7% +$35.7K
FICO icon
29
Fair Isaac
FICO
$29.2B
$4.79M 1.15%
11,448
+163
+1% +$59.5K
ILMN icon
30
Illumina
ILMN
$28.2B
$4.57M 1.1%
12,684
-910
-7% -$293K
ZBRA icon
31
Zebra Technologies
ZBRA
$12.7B
$4.36M 1.05%
17,028
+481
+3% +$113K
AKBA icon
32
Akebia Therapeutics
AKBA
$359M
$4.3M 1.04%
316,933
-2,140
-0.7% -$22.1K
TRU icon
33
TransUnion
TRU
$15.4B
$4.23M 1.02%
48,588
+976
+2% +$77.9K
XLNX
34
DELISTED
Xilinx Inc
XLNX
$4.2M 1.01%
42,676
+532
+1% +$47.2K
VOO icon
35
Vanguard S&P 500 ETF
VOO
$974B
$3.22M 0.77%
11,355
+85
+0.8% +$22.9K
CSCO icon
36
Cisco
CSCO
$441B
$3.17M 0.76%
68,024
+3,947
+6% +$173K
SLP icon
37
Simulations Plus
SLP
$369M
$3.13M 0.75%
52,314
-1,833
-3% -$80.7K
LIN icon
38
Linde
LIN
$237B
$3.03M 0.73%
14,284
+74
+0.5% +$14.3K
MDT icon
39
Medtronic
MDT
$106B
$2.67M 0.64%
29,059
+1,272
+5% +$122K
PFE icon
40
Pfizer
PFE
$143B
$2.61M 0.63%
84,100
+3,697
+5% +$126K
AAPL icon
41
Apple
AAPL
$4.9T
$2.58M 0.62%
28,256
+676
+2% +$52.4K
EEFT icon
42
Euronet Worldwide
EEFT
$3.1B
$2.58M 0.62%
26,893
+1,017
+4% +$93.9K
INTC icon
43
Intel
INTC
$478B
$2.22M 0.53%
37,035
+1,820
+5% +$109K
HON icon
44
Honeywell
HON
$71.3B
$2.19M 0.53%
16,061
-827
-5% -$109K
AMZN icon
45
Amazon
AMZN
$2.66T
$2.17M 0.52%
15,760
+11,060
+235% +$1.34M
CCI icon
46
Crown Castle
CCI
$34.6B
$2.13M 0.51%
12,731
-3,744
-23% -$603K
WMT icon
47
Walmart Inc
WMT
$909B
$2.12M 0.51%
53,055
-12,843
-19% -$528K
KLAC icon
48
KLA
KLAC
$278B
$2.11M 0.51%
108,540
-4,990
-4% -$85.3K
VZ icon
49
Verizon
VZ
$182B
$2.06M 0.5%
37,448
+868
+2% +$48.8K
PLD icon
50
Prologis
PLD
$140B
$2.03M 0.49%
21,746
+766
+4% +$68.3K

Similar funds

Stanley-Laman Group's Q2 2020 Portfolio in Review

As of Q2 2020, Stanley-Laman Group held 270 positions worth $416M, up 26% from $329M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Stanley-Laman Group's Q2 2020 filing shows 32 new, 111 increased, 38 reduced and 36 closed positions. Its largest new stake was Advanced Micro Devices: 109,759 shares worth $5.77M. The largest sale was Dover, an estimated $4.31M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Stanley-Laman Group's largest Q2 2020 buy was Advanced Micro Devices: 109,759 shares worth $5.77M.
  • Stanley-Laman Group added most to Leidos in Q2 2020, an estimated $5.21M increase.
  • Stanley-Laman Group's biggest Q2 2020 reduction was Crown Castle, cutting an estimated $603K.
  • Stanley-Laman Group fully exited Dover in Q2 2020, selling an estimated $4.31M.
  • Stanley-Laman Group's ten largest holdings make up 20% of its $416M portfolio in Q2 2020.
  • Stanley-Laman Group opened 32 new positions and closed 36 in Q2 2020.
  • Stanley-Laman Group's portfolio value rose 26% quarter-over-quarter to $416M.

Based on Stanley-Laman Group's 13F filing for Q2 2020, filed 20 Jul 2020.